The DOI matches its Crossref record.
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
Abstract
We developed a sensitive and specific two-site radioimmunoassay (IRMA) for human osteocalcin using human osteocalcin as a standard and two monoclonal antibodies raised against human osteocalcin purified from human cortical bone, a solid-phase anti-25–37 region and a tracer anti-5–13 sequence of the molecule. A wide range of osteocalcin levels (up to 300 ng/ml) can be measured with a sensitivity of 0.4 ng/ml. The intra- and interassay coefficients of variation are less than 4 and 6%, respectively. The recovery of human osteocalcin from serum samples ranges from 96 to 103%. IRMA was linear for serial sample dilutions in a wide range of serum osteocalcin levels, even in patients with chronic renal failure on hemodialysis. Depletion of serum in intact osteocalcin demonstrated that IRMA detects, in addition to the intact peptide, a large N-terminal midregion fragment that represents about 50% of total osteocalcin levels in normals and patients with Paget's disease and up to 75% in patients with chronic renal failure. This large fragment, previously unrecognized because it cannot be distinguished from intact osteocalcin with gel filtration chromatography, is not generated in vitro by incubation of the serum up to 26 h. We measured osteocalcin in the serum of 309 healthy adults (180 men and 129 women, age range 20–95 years), 36 patients with Paget's disease, 12 patients with primary hyperparathyroidism, 70 patients with chronic renal failure on hemodialysis, and 10 patients on corticosteroid therapy, simultaneously with human IRMA and with a conventional radioimmunoassay (RIA) based on bovine reagents. A tight correlation (r = 0.889) was observed between the two assays in the normal population, but the values obtained with IRMA were about threefold higher (mean 23.3 ± 10.5 versus 7.5 ± 3.4 ng/ml) than those obtained with RIA. Reported as Z scores, that is, number of standard deviations from the predicted normal mean adjusted for sex and age, these two assays (IRMA and RIA) gave concordant results in patients with Paget's disease (4.05 ± 6.21 versus 2.41 ± 2.53), primary hyperparathyroidism (4.14 ± 7.17 versus 2.13 ± 2.28), chronic renal failure (25.32 ± 24.49 versus 6.93 ± 5.48), and glucocorticoid treatment (-1.48 ± 0.78 versus −1.11 ± 0.57). However, IRMA was more discriminant from controls for all these metabolic bone diseases because the absolute values of mean Z scores with IRMA were significantly higher than those obtained with the RIA (p < 0.05–0.0001). We conclude that this new human-specific IRMA of osteocalcin may be more sensitive than bovine RIA for the clinical investigation of metabolic bone diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Dr. Garnero, P., Sornay-Rendu, E., Chapuy, M.-C., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110307 · Cited by 1,001
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M.-C., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Bréart, G., Meunier, P. J., & Dr. Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 989
Self-citationGarnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Self-citationGarnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Self-citationBass, S., Pearce, G., Bradney, M., Hendrich, E., Delmas, P. D., Harding, A., & Seeman, E. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.500 · Cited by 616
Garnero, P., Piperno, M., Gineyts, E., Christgau, S., Delmas, P. D., & Vignon, E. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.6.619 · Cited by 475
Self-citationJournal of Bone and Mineral Research
Delmas, P. D. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081323 · Cited by 454
The differing tempo of growth in bone size, mass, and density in girls is region-specific
Bass, S., Delmas, P. D., Pearce, G., Hendrich, E., Tabensky, A., & Seeman, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7060 · Cited by 413
Vergnaud, P., Garnero, P., Meunier, P. J., Bréart, G., Kamihagi, K., & Delmas, P. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3805 · Cited by 389
Self-citationSikavitsas, V. I., Bancroft, G. N., & Mikos, A. G. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10150 · Cited by 388
Bone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Garnero, P. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.4.1046 · Cited by 362
Self-citationNuttall, M. E., Patton, A. J., Olivera, D. L., Nadeau, D. P., & Gowen, M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.371 · Cited by 354
Increased Bone Resorption in Moderate Smokers with Low Body Weight: The Minos Study
Szulc, P. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.666 · Cited by 144
Caillot-Augusseau, A., Vico, L., Heer, M., Voroviev, D., Souberbielle, J.-C., Zitterman, A., Alexandre, C., & Lafage-Proust, M.-H. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.8.1136 · Cited by 133
“The Elsa-OsteoTM IRMA (CIS-bio International) is a two-site IRMA for the determination of intact and fragmented BGP that uses a solid phase ( 18 ). The intra- and interassay CVs were ,4% and 6%, respectively.”
BackgroundKunutsor, S. K., Apekey, T. A., & Laukkanen, J. A. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0058-x · Cited by 107
Garnero, P., Jouvenne, P., Buchs, N., Delmas, P. D., & Miossec, P. (1999) · Bone · doi:10.1016/s8756-3282(98)00193-8 · Cited by 79
Self-citationSzulc, P., Claustrat, B., Munoz, F., Marchand, F., & Delmas, P. D. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02117.x · Cited by 48
Metadata
- Authors
- Garnero, P., Grimaux, M., Demiaux, B., Preaudat, C., Seguin, P., & Dr. Delmas, P. D.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-12-01
- Volume
- 7
- Issue
- 12
- Pages
- 1389-1398
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1972641924
- Cited by
- 183
- References
- 0
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.